Longevity Magazine A review journal of healthspan, preventative medicine and ageing
Index

Analysis

How the field is practised rather than what the evidence says about a compound. Delivery, regulation, cost and the decisions patients are actually asked to make.

4 piecesLast checked 31 July 2026

What this section is

Analysis pieces cover the market rather than the molecule: how longevity and aesthetic services are delivered in the United Kingdom, what they cost, how they are regulated, and which of the claims made for them the evidence supports. They carry no grade, because a grade attaches to a stated intervention claim and these pieces do not make one. A small number carry a single disclosed editorial link to a named organisation, declared on the page and never sold.

  1. 01

    The aesthetic clinic evolution: why branding, design and digital experience now define clinical success

    Presentation is not the opposite of clinical quality. It is now the channel through which most patients try to judge it, which is a problem worth taking seriously.

    Analysis
  2. 02

    The complete guide to modern aesthetic medicine

    A structural guide to the field: the treatment families, the evidence behind each, the regulatory floor, and the questions that decide the outcome.

    Analysis
  3. 03

    Longevity and aesthetics: the future of ageing well in London

    The two fields are converging commercially faster than they are converging scientifically. A guide to telling the difference.

    Analysis
  4. 04

    The future of longevity: revolutionary anti-ageing innovations transforming healthcare

    Five fields described as revolutionary. Where each one genuinely stands, measured against the evidence rather than the announcement.

    Analysis